Literature DB >> 4791300

In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

H J Harwick, G M Kalmanson, L B Guze.   

Abstract

Minimum inhibitory and bactericidal concentrations of four antibiotics and their combinations were determined for 38 strains of enterococci by a microtitration tube dilution technique. The drugs were ampicillin, vancomycin, gentamicin, and streptomycin; the combinations were ampicillin-gentamicin, ampicillin-streptomycin, vancomycin-gentamicin, and vancomycin-streptomycin. At achievable serum concentrations, ampicillin alone killed 60% of strains, whereas combination with streptomycin increased this to 90% and with gentamicin to 100%. Vancomycin alone showed striking inhibitory activity, but very poor bactericidal activity at achievable concentrations. Combination with one of the aminoglycosides increased the bactericidal activity substantially. When combined with ampicillin, gentamicin was both more active and showed synergistic bactericidal activity significantly more often (P < 0.01) than streptomycin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4791300      PMCID: PMC444563          DOI: 10.1128/AAC.4.4.383

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Vancomycin-streptomycin synergism in enterococcal endocarditis.

Authors:  G O Westenfelder; P Y Paterson; B E Reisberg; G M Carlson
Journal:  JAMA       Date:  1973-01-01       Impact factor: 56.272

2.  Application of microtitration techniques to bacteriostatic and bactericidal antibiotic susceptibility testing.

Authors:  H J Harwick; P Weiss; F R Fekety
Journal:  J Lab Clin Med       Date:  1968-09

3.  Kinetics of the synergism of penicillin-streptomycin and penicillin-kanamycin for enterococci and its relationship to L-phase variants.

Authors:  W L Hewitt; S J Seligman; R A Deigh
Journal:  J Lab Clin Med       Date:  1966-05

4.  Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patients.

Authors:  C K Friedberg; K M Rosen; P A Bienstock
Journal:  Arch Intern Med       Date:  1968-08

5.  Synergism of vancomycin and streptomycin for enterococci.

Authors:  G L Mandell; E Lindsey; E W Hook
Journal:  Am J Med Sci       Date:  1970-05       Impact factor: 2.378

6.  Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center.

Authors:  G L Mandell; D Kaye; M E Levison; E W Hook
Journal:  Arch Intern Med       Date:  1970-02

7.  Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in rats.

Authors:  F L Sapico; G M Kalmanson; J Z Montgomerie; W L Hewitt; L B Guze
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

8.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

9.  Antibiotic synergism: enhanced susceptibility of enterococci to combinations of streptomycin and penicillins or cephalosporins.

Authors:  F R Fekety; P Weiss
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

10.  Ampicillin in the treatment of enterococcal endocarditis.

Authors:  H N Beaty; M Turck; R G Petersdorf
Journal:  Ann Intern Med       Date:  1966-10       Impact factor: 25.391

View more
  24 in total

1.  Characterization of the unique function of a reduced amide bond in a cytolytic peptide that acts on phospholipid membranes.

Authors:  J E Oh; K H Lee
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 2.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 3.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.

Authors:  T L Hodges; S Zighelboim-Daum; G M Eliopoulos; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Infectious disease emergencies. Part II: patients presenting with cardiac decompensation or circulatory insufficiency (shock).

Authors: 
Journal:  West J Med       Date:  1976-08

6.  An analysis of group D streptococci recovered from cancer patients.

Authors:  V M Young; M J Morris; M R Moody; S C Schimpff; J W Gerster; P H Wiernik
Journal:  Infection       Date:  1978       Impact factor: 3.553

7.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

8.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

Authors:  D F Sahm; J Kissinger; M S Gilmore; P R Murray; R Mulder; J Solliday; B Clarke
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals.

Authors:  G G Zhanel; G K Harding; S Rosser; D J Hoban; J A Karlowsky; M Alfa; A Kabani; J Embil; A Gin; T Williams; L E Nicolle
Journal:  Can J Infect Dis       Date:  2000-01

10.  Comparative in vitro activity of nafcillin, oxacillin, and methicillin in combination with gentamicin and tobramycin against enterococci.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.